Synthesis of Isoquinoline Derivatives through RhodiumACTHNUTRGNE(NUG III)-Catalyzed Reactions of Benzylamines
1-Methyl-3,4-dipropylisoquinoline (7i) [CAS No. 362061-
46-9]: 1H NMR (400 MHz, CDCl3): d=8.07 (d, J=8.3 Hz,
1H), 7.96 (d, J=8.5 Hz, 1H), 7.64 (t, J=7.0 Hz, 1H), 7.48
(t, J=7.9 Hz), 1H), 3.00–2.96 (m, 2H), 2.93–2.89 (m, 2H),
2.91 (s, 3H), 1.84–1.74 (m, 2H), 1.72–1.62 (m, 2H), 1.09 (t,
J=7.3 Hz, 3H), 1.05 (t, J=7.3 Hz, 3H); 13C NMR
(100 MHz, CDCl3): d=155.8, 151.9, 135.6, 129.6, 126.37,
126.31, 126.2, 125.4, 123.8, 37.7, 30.0, 24.4, 24.0, 22.6, 14.8,
14.6.
128.1, 125.8, 125.4, 121.6, 37.5, 35.1, 30.6, 30.3, 24.3, 23.7,
23.2, 21.9, 14.9, 14.6, 14.3, 14.2; IR (CDCl3): n=3069, 2959,
2931, 2872, 1771, 1715, 1605, 1575, 1463, 1378, 1259, 1125,
897, 802, 718 cmÀ1; HR-MS (EI+): m/z=323.2610, calcd. for
C23H33N [M]+: 323.2613.
1-Methyl-8-(oct-4-en-4-yl)-3,4-dipropylisoquinoline (9b):
1H NMR (400 MHz, CDCl3): d=7.86 (dd, J=8.6 Hz, 0.9 Hz,
1H), 7.52–7.48 (m, 1H), 7.16 (dd, J=6.8 Hz, 0.9 Hz, 1H),
5.51 (t, J=7.1 Hz, 1H), 2.99–2.88 (m, 4H), 2.96 (s, 3H),
2.75–2.67 (m, 1H), 2.32–2.15 (m, 2H), 2.11–2.04 (m, 1H),
1.85–1.75 (m, 2H), 1.73–1.64 (m, 2H), 1.59–1.46 (m, 2H),
1.38–1.20 (m, 2H), 1.10 (t, J=7.3 Hz, 3H), 1.06 (t, J=
7.3 Hz, 3H), 1.01 (t, J=7.3 Hz, 3H), 0.85 (t, J=7.3 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=155.9, 151.1, 144.19,
144.13, 137.1, 129.7, 128.5, 128.4, 126.1, 124.8, 122.7, 37.6,
36.4, 30.6, 30.4, 27.2, 24.3, 23.9, 22.8, 21.6, 14.8, 14.6, 14.3; IR
(CDCl3): n=3071, 2960, 2872, 2732, 1699, 1597, 1462, 1377,
1089, 807 cmÀ1; HR-MS (FAB+): m/z=338.2856, calcd. for
C24H35N [M+H]+: 338.2842.
1-Cyclohexyl-3,4-dipropylisoquinoline
(7j):
1H NMR
(400 MHz, CDCl3): d=8.16 (d, J=8.4 Hz, 1H), 7.94 (d, J=
8.4 Hz, 1H), 7.57 (t, J=7.2 Hz, 1H), 7.43 (t, J=7.6 Hz, 1H),
3.50–3.45 (m, 1H), 2.97–2.88 (m, 4H), 1.94–1.77 (m, 9H),
1.70–1.61 (m, 2H), 1.55–1.46 (m, 2H), 1.42–1.35 (m, 1H),
1.08 (t, J=7.2 Hz, 3H), 1.01 (t, J=7.2 Hz, 3H); 13C NMR
(100 MHz, CDCl3): d=162.3, 151.7, 135.9, 128.9, 125.4,
125.2, 125.0, 124.7, 123.9, 41.6, 37.3, 32.8, 30.0, 27.1, 26.6,
24.2, 23.3, 12.9, 14.5; IR (CDCl3): n=3071, 2958, 2929, 2870,
2853, 1615, 1565, 1504, 1449, 1377, 1323, 985, 761 cmÀ1; HR-
MS (FAB+): m/z=296.2383, calcd. for C21H29N [M+H]+:
296.2373.
1-Cyclohexyl-8-(oct-4-en-4-yl)-3,4-dipropylisoquinoline
(9c): 1H NMR (400 MHz, CDCl3): d=7.85 (d, J=8.4 Hz,
1H), 7.45 (t, J=7.7 Hz, 1H), 7.11 (dd, J=6.8 Hz, 0.7 Hz,
1H), 5.52 (t, J=7.0 Hz, 1H), 3.86–3.81 (m, 1H), 2.96–2.82
(m, 4H), 2.71–2.64 (m, 1H), 2.25 (q, J=7.3 Hz, 2H), 2.18–
2.08 (m, 2H), 1.90–1.81 (m, 4H), 1.70–1.62 (m, 4H), 1.60–
1.47 (m, 3H), 1.42–1.18 (m, 6H), 1.09 (t, J=7.3 Hz, 3H),
1.02 (td, J=7.3 Hz, 1.0 Hz, 6H), 0.83 (t, J=7.2 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=163.1, 151.0, 144.5, 143.2,
137.3, 128.6, 128.1, 127.8, 125.2, 123.1, 122.9, 42.9, 37.2, 35.9,
34.7, 31.9, 30.8, 30.5, 27.3, 27.2, 26.6, 24.1, 23.1, 23.0, 21.7,
15.0, 14.6, 14.49, 14.47; IR (CDCl3): n=3075, 2958, 2927,
1-Hexyl-3,4-dipropylisoquinoline
(7k):
1H NMR
(400 MHz, CDCl3): d=8.11 (d, J=8.3 Hz, 1H), 7.96 (d, J=
8.5 Hz, 1H), 7.65–7.61 (m, 1H), 7.50–7.46 (m, 1H), 3.23 (t,
J=7.9 Hz, 2H), 2.99–2.95 (m, 2H), 2.93–2.89 (m, 2H), 1.85–
1.74 (m, 4H), 1.72–1.62 (m, 2H), 1.50–1.43 (m, 2H), 1.37–
1.29 (m, 2H), 1.09 (t, J=7.2 Hz, 3H), 1.03 (t, J=7.2 Hz,
3H), 0.88 (t, J=6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3):
d=159.7, 151.9, 135.9, 129.4, 126.16, 126.10, 125.4, 125.3,
123.9, 37.6, 35.9, 32.0, 30.5, 30.0, 29.8, 24.3, 24.0, 22.9, 14.9,
14.5, 14.3; IR (CDCl3): n=3071, 2957, 2929, 2871, 1616,
1566, 1504, 1463, 1378, 1260,1028, 759 cmÀ1
; HR-MS
2870, 2851, 1597, 1557, 1450, 1378, 1225, 982, 891, 771 cmÀ1
;
(FAB+): m/z=298.2540, calcd. for C21H31N [M+H]+:
298.2529.
HR-MS (EI+): m/z=405.3389, calcd. for C29H43N [M]+:
405.3396.
1-Phenyl-3,4-dipropylisoquinoline (7l) [CAS No.387862-
1-Hexyl-8-(oct-4-en-4-yl)-3,4-dipropylisoquinoline
(9d):
1
67-1]: H NMR (400 MHz, CDCl3): d=8.03 (dd, J=8.5 Hz,
1H NMR (400 MHz, CDCl3): d=7.85 (d, J=8.4 Hz, 1H),
7.50–7.46 (m, 1H), 7.13 (d, J=6.7 Hz, 1H), 5.60 (t, J=
7.0 Hz, 1H), 3.60–3.53 (m, 1H), 3.01–2.81 (m, 5H), 2.71–
2.64 (m, 1H), 2.23 (q, J=7.5 Hz, 2H), 2.11–2.04 (m, 1H),
1.86–1.77 (m, 2H), 1.73–1.63 (m, 2H), 1.57–1.47 (m, 4H),
1.25–1.15 (m, 8H), 1.09 (t, J=7.2 Hz, 3H), 1.05–1.00 (m,
6H), 0.85–0.78 (m, 6H); 13C NMR (100 MHz, CDCl3): d=
159.9, 151.2, 144.2, 143.7, 137.3, 128.8, 128.7, 128.2, 125.7,
123.8, 122.9, 38.2, 37.5, 36.3, 32.2, 31.4, 30.8, 30.5, 29.7, 24.3,
23.7, 23.0, 22.9, 21.7, 14.9, 14.6, 14.4, 14.33, 14.31; IR
(CDCl3): n=3068, 2959, 2932, 2872, 1710, 1463, 1378, 1179,
1089, 772 cmÀ1; HR-MS (FAB+): m/z=408.3622, calcd. for
C29H45N [M+H]+: 408.3625.
2.8 Hz, 2H), 7.68–7.64 (m, 3H), 7.53–7.40 (m, 4H), 3.10–
3.00 (m, 4H), 1.91–1.82 (m, 2H), 1.80–1.71 (m, 2H), 1.15 (t,
J=7.3 Hz, 3H), 1.06 (t, J=7.3 Hz, 3H); 13C NMR
(100 MHz, CDCl3): d=258.3, 152.4, 140.4, 136.3, 130.2,
129.6, 128.4, 128.38, 128.30, 127.3, 125.5, 125.4, 123.5, 37.6,
30.2, 24.3, 23.9, 14.9, 14.5.
1-(But-1-en-1-yl)-1-propyl-1H-isoindole (8): 1H NMR
(400 MHz, CDCl3): d=8.58 (s, 1H), 7.33 (t, J=7.7 Hz, 1H),
6.99 (d, J=7.4 Hz, 1H), 6.79 (d, J=8.0 Hz, 1H), 5.71 (d, J=
15.5 Hz, 1H), 5.63–5.56 (m, 1H), 3.91 (s, 3H), 2.05–1.95 (m,
3H), 1.84–1.77 (m, 1H), 1.14–1.04 (m, 1H), 0.93 (t, J=
7.4 Hz, 3H), 0.88–0.76 (m, 4H); 13C NMR (100 MHz,
CDCl3): d=158.28, 158.24, 154.5, 131.4, 130.5, 129.4, 127.8,
115.2, 109.2, 84.1, 55.6, 40.6, 25.8, 17.2, 14.5, 13.7; IR
(CDCl3): n=3087, 3006, 2959, 2934, 2911, 2872, 1702, 1612,
1547, 1269, 1029, 970, 788 cmÀ1; HR-MS (FAB+): m/z=
243.1626, calcd. for C16H21NO [M]+: 243.1623.
8-(Oct-4-en-4-yl)-1-phenyl-3,4-dipropylisoquinoline (9e):
1H NMR (400 MHz, CDCl3): d=7.96 (d, J=8.6 Hz, 1H),
7.60–7.57 (m, 2H), 7.40–7.28 (m, 5H), 5.29 (t, J=7.2 Hz,
1H), 3.07–3.03 (m, 2H), 3.01–2.89 (m, 2H), 1.84–1.60 (m,
8H), 1.27–1.05 (m, 2H), 1.12 (t, J=7.3 Hz, 3H), 1.03–0.92
(m, 2H), 1.01 (t, J=7.3 Hz, 3H), 0.63 (t, J=7.3 Hz, 3H),
0.56 (t, J=7.3 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=
159.4, 152.1, 144.7, 140.7, 138.4, 135.8, 131.8, 130.4, 129.7,
129.5, 128.9, 128.1, 127.1, 126.5, 126.2, 125.0, 123.1, 37.6,
33.0, 30.3, 30.2, 24.4, 24.1, 22.7, 21.8, 14.8, 14.5, 14.1, 13.8; IR
(CDCl3): n=3067, 2960, 2872, 1690, 1614, 1557,1461, 1381,
1086, 761 cmÀ1; HR-MS (EI+): m/z=399.2923, calcd. for
C29H37N [M]+: 399.2926
8-(Oct-4-en-4-yl)-3,4-dipropylisoquinoline (9a): 1H NMR
(400 MHz, CDCl3): d=9.26 (s, 1H), 7.84 (d, J=8.6 Hz, 1H),
7.60–7.56 (m, 1H), 7.24 (d, J=7.0 Hz, 1H), 5.48 (t, J=
7.3 Hz, 1H), 3.02–2.98 (m, 2H), 2.95–2.91 (m, 2H), 2.51 (t,
J=7.6 Hz, 2H), 2.27 (q, J=7.3 Hz, 2H), 1.86–1.77 (m, 2H),
1.74–1.64 (m, 2H), 1.54–1.45 (m, 2H), 1.35–1.25 (m, 2H),
1.10 (t, J=7.3 Hz, 3H), 1.04 (t, J=7.3 Hz, 3H), 0.99 (t, J=
7.3 Hz, 3H), 0.87 (t, J=7.3 Hz, 3H); 13C NMR (100 MHz,
CDCl3): d=152.3, 149.0, 144.5, 138.2, 135.9, 132.8, 129.5,
Adv. Synth. Catal. 2013, 355, 2667 – 2679
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
2677